This free whitepaper will demonstrate how Clinical Ink’s ePRO technology, Engage, can solve long-standing issues with paper-based Phase I clinical trials, including the lack of data attributability, the inability to monitor patient activity in real-time and the time it takes to transcribe subject reported data into an ECF.
Read this whitepaper to learn how Engage revolutionizes Phase I trials with:
- Timely, quality results that save on study budgets
- A tested BYOD option
- An ePRO library with re-usable questionnaires
- Better, cleaner data with a back-end database
- Agile project management and software configuration methodology